Article Information
PubMed
Print ISSN
Online ISSN
History
- Received May 27, 2014
- Accepted October 31, 2014
- Published online November 24, 2014.
Article Versions
- Earlier version (November 4, 2014 - 08:31).
- Earlier version (November 5, 2014 - 07:28).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Katarina Rubin,
- Annika Janefeldt,
- Linda Andersson,
- Zsofia Berke,
- Ken Grime, and
- Tommy B. Andersson
- AstraZeneca R&D, Mölndal, Sweden; and Respiratory, Inflammation and Autoimmunity Innovative Medicines Drug Metabolism and Pharmacokinetics (K.R., K.G.), Cardiovascular and Metabolic Diseases Innovative Medicines (A.J., T.B.A.), Drug Safety and Metabolism Drug Metabolism and Pharmacokinetics (L.A.), Personalized Healthcare and Biomarkers (Z.B.), and Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (T.B.A.)
- Address correspondence to:
Dr. Katarina Rubin, Department of Drug Metabolism and Pharmacokinetics, Respiratory, Inflammation and Autoimmune Disease, AstraZeneca R&D, Mölndal, SE 43183 Mölndal, Sweden. E-mail: katarina.rubin{at}astrazeneca.com